ReviewFrontiers in cardiovascular medicine2022

Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: A systematic review, meta-analysis and integrative bioinformatics analysis.

Sicong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.